AB68,1550,13 (4) Rebates and price concessions. By March 1 annually, each pharmacy benefit manager shall report to the commissioner the amount received from manufacturers as drug rebates and the value of price concessions, expressed as a percentage of the wholesale acquisition cost, provided by manufacturers for each drug.

AB68,1550,17 (5) Manufacturer-sponsored assistance programs. By March 1 annually, each manufacturer shall provide the commissioner with a description of each manufacturer-sponsored patient assistance program in effect during the previous year that includes all of the following:

AB68,1550,18 (a) The terms of the programs.

AB68,1550,19 (b) The number of prescriptions provided to state residents under the program.

AB68,1550,21 (c) The total market value of assistance provided to residents of this state under the program.

AB68,1550,24 (6) Pharmacy services administrative organizations. By March 1 annually, each pharmacy services administrative organization shall report to the commissioner all of the following information:

AB68,1551,2 (a) The negotiated reimbursement rate of the 25 prescription drugs with the highest reimbursement rates during the previous year.

AB68,1551,4 (b) The 25 prescription drugs with the highest year-to-year change in reimbursement rate for the previous year.

AB68,1551,5 (c) The schedule of fees charged by the organization to pharmacies.

AB68,1551,11 (7) Certification and penalties for noncompliance. Each manufacturer and pharmacy services administrative organization that is required to report under this section shall certify each report as accurate under the penalty of perjury. A manufacturer or pharmacy services administrative organization that fails to submit a report required under this section is subject to a forfeiture of no more than $10,000 each day the report is overdue.

AB68,1551,14 (8) Hearing and public reporting. (a) The commissioner shall publicly post manufacturer price justification documents. The commissioner shall keep any trade secret or proprietary information confidential.

AB68,1551,20 (b) The commissioner shall analyze data collected under this section and publish annually a report on emerging trends in prescription prices and price increases and shall annually conduct a public hearing based on the analysis under this paragraph. The report under this paragraph shall include analysis of manufacturer prices and price increases and analysis of how pharmacy benefit manager discounts and net costs compare to retail prices paid by patients.

AB68,2968 Section 2968. 632.868 of the statutes is created to read:

AB68,1551,22 632.868 Insulin safety net programs. (1) Definitions. In this section:

AB68,1551,24 (a) “Manufacturer" means a person engaged in the manufacturing of insulin that is self-administered on an outpatient basis.

AB68,1551,25 (b) “Navigator" has the meaning given in s. 628.90 (3).

AB68,1552,2 (c) “Patient assistance program” means a program established by a manufacturer under sub. (3) (a).

AB68,1552,3 (d) “Pharmacy" means an entity licensed under s. 450.06 or 450.065.

AB68,1552,6 (e) “Urgent need of insulin" means having less than a 7-day supply of insulin readily available for use and needing insulin in order to avoid the likelihood of suffering a significant health consequence.

AB68,1552,8 (f) “Urgent need safety net program” means a program established by a manufacturer under sub. (2) (a).

AB68,1552,12 (2) Urgent need safety net program. (a) Establishment of program. No later than July 1, 2022, each manufacturer shall establish an urgent need safety net program to make insulin available in accordance with this subsection to individuals who meet the eligibility requirements under par. (b).

AB68,1552,14 (b) Eligible individual. An individual shall be eligible to receive insulin under an urgent need safety net program if all of the following conditions are met:

AB68,1552,15 1. The individual is in urgent need of insulin.

AB68,1552,16 2. The individual is a resident of this state.

AB68,1552,17 3. The individual is not receiving public assistance under ch. 49.

AB68,1552,22 4. The individual is not enrolled in prescription drug coverage through an individual or group health plan that limits the total cost sharing amount, including copayments, deductibles, and coinsurance, that an enrollee is required to pay for a 30-day supply of insulin to no more than $75, regardless of the type or amount of insulin prescribed.

AB68,1552,24 5. The individual has not received insulin under an urgent need safety net program within the previous 12 months, except as allowed under par. (d).

AB68,1553,4 (c) Provision of insulin under an urgent need safety net program. 1. In order to receive insulin under an urgent need safety net program, an individual who meets the eligibility requirements under par. (b) shall provide a pharmacy with all of the following:

AB68,1553,8 a. A completed application, on a form prescribed by the commissioner that shall include an attestation by the individual, or the individual's parent or legal guardian if the individual is under the age of 18, that the individual meets all of the eligibility requirements under par. (b).